MedTech Innovator
HealthTech & MedTech · Run by MedTech Innovator · Los Angeles, CA
Every field is checked against a primary source where we can. How we verify.
The facts
All fields verified Jul 22, 2026- Terms model
- Non-dilutiveGives money that does not take equity: grants, prizes, or credits. Your ownership is untouched.
- Investment
- up to $500,000
- Equity taken
- Not publishedEquity-free nonprofit accelerator; early-stage (pre-Series B) companies compete for up to $500,000 in non-dilutive awards. No equity taken and no fees. equity_pct null because no equity is taken. Includes complimentary AdvaMed Accel membership and conference registrations. DEADLINE/STATUS NOTE: 2026 cohort application deadline was Dec 16, 2025 (extended), now passed; 2027 applications expected to open in fall 2026 per program site. Program runs Jun-Oct 2026 (~22 weeks, approximate).
- Program length
- 22 weeks
- Format
- Hybrid
- Location
- Los Angeles, CA
- Cohorts per year
- 1
- Cohort size
- 50+
- Stage focus
- pre-seed to Series C (eligible up to Series C raised)
- Sub-vertical
- medical devices, diagnostics, digital health
- Demographic focus
- Not published
- Backers
- AdvaMed
- Notable alumni
- Not published
Terms notes: Equity-free nonprofit accelerator; early-stage (pre-Series B) companies compete for up to $500,000 in non-dilutive awards. No equity taken and no fees. equity_pct null because no equity is taken. Includes complimentary AdvaMed Accel membership and conference registrations. DEADLINE/STATUS NOTE: 2026 cohort application deadline was Dec 16, 2025 (extended), now passed; 2027 applications expected to open in fall 2026 per program site. Program runs Jun-Oct 2026 (~22 weeks, approximate).
Get HealthTech & MedTech deadline alerts
One digest a week. Deadline alerts only for verticals you pick. Unsubscribe anytime.
Terms in plain English
MedTech Innovator is a nonprofit accelerator that takes no equity and charges no participation fee. There is no standard check for every company; instead, early-stage companies (pre-Series B) are paired with corporate-partner mentors and compete for up to $500,000 in non-dilutive awards over the course of the program. The program runs largely virtually from June to October, with required in-person attendance by a senior leader at events in June and October, and all companies receive complimentary AdvaMed Accel membership.
Who this is actually for
Medical device, diagnostic, and digital health companies from pre-seed up through Series C with at least a prototype and some proof-of-concept evidence. Best fit for teams that want corporate mentorship, industry visibility, and a shot at competed awards rather than a cash-for-equity deal, and that can send a co-founder, CEO, or senior leader to the June and October in-person events.
Application windows
2026 cohort: Applications close Dec 16, 2025.
Verified date not recordedSource2027 cohort, applications expected fall 2026: Timing expected, exact dates not yet confirmed.
Verified date not recorded
Compare this program
Put MedTech Innovator side by side with up to two others to weigh cash, equity, and timing.
Compare MedTech InnovatorGuides that explain these terms
Plain-English mechanics, with worked hypothetical numbers.
More like MedTech Innovator
Sources
Everything above was checked against these, verified Jul 22, 2026.